Skip to main content
[Preprint]. 2022 Aug 30:2022.08.29.22279355. [Version 1] doi: 10.1101/2022.08.29.22279355

Table 1B.

Demographics of the PCOS cohort.

All patients On Levothyroxine On metformin p-value
n 282 86 196
DEMOGRAPHICS
age 33.18 (8.42%) 35.81 (8.06%) 32.03 (8.33%) <0.001
BMI 37.90 (8.94) 36.73 (8.38) 38.43 (9.15) 0.173
length of stay 7.04 (39.95) 12.51 (64.96) 4.63 (21.00%) 0.128
INPATIENT/OUTPATIENT
Inpatient or ED 72 (25.5%) 28 (32.6%) 44 (22.4%) 0.1
RACE 0.379
White 190 (67.4) 65 (75.6) 125 (63.8) 0.059
Black or African American 33 (11.7) < 20 > 20
Asian < 20 < 20 < 20
Other < 20 < 20 < 20
Native Hawaiian or Other Pacific Islander < 20 < 20 < 20
ETHNICITY 0.85
Hispanic or Latino 63 (24.8) < 20 >20
Not Hispanic or Latino 191 (75.2) 59 (76.6) 132 (74.6)
CCI 30 (10.6) < 20 < 20 0.008
Current or former smoker 59 (20.9) < 20 >20 0.267
HOSPITAL EVENTS
AKI in hospital <20 <20 <20 0.671
Invasive ventilation <20 <20 <20 0.671
ECMO 0 0 0 -
COMORBIDITIES
prediabetes 84 (29.8%) 18 (20.9%) 66 (33.7%) 0.044
neoplasm 57 (20.2) 22 (25.6) 35 (17.9) 0.185
hypertension 54 (19.1) < 20 >20 0.992
chronic respiratory disease 49 (17.4) < 20 >20 1
heart disease 21 (7.4) < 20 < 20 0.302
liver disease < 20 < 20 < 20 0.005
nicotine dependence < 20 < 20 < 20 0.966
kidney disease < 20 < 20 < 20 0.759